© 2003 BMJ Publishing Group Ltd
ONLINE MUTATION REPORT
Meta-analysis of age at onset in spastin-associated hereditary spastic paraplegia provides no evidence for a correlation with mutational class
1 Genetics Program (Department of Medicine), Boston University School of Medicine, Boston, MA 02118, USA
2 INSERM U 289 and Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France
3 Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA
4 Center for Human Genetics, Duke University Medical Center, Durham, NC 27710, USA
5 Department of Neurology, Northwestern University Medical School Chicago, 300 E. Superior Street, Tarry 13-715, Chicago, IL 60611, USA
6 Department of Medical Genetics, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, University of Cambridge, Cambridge, UK
Correspondence to:
Correspondence to:
Dr E Reid, Department of Medical Genetics, University of Cambridge, Box 134, Addenbrookes Hospital, Cambridge CB2 2QQ UK;
ereid@hgmp.mrc.ac.uk
Abbreviations: HSP, hereditary spastic paraplegia
Keywords: hereditary spastic paraplegia; spastin
| The first 150 words of the full text of this article appear below. |
The hereditary spastic paraplegias (HSPs) are a group of single gene disorders in which the corticospinal tracts fail to develop normally, or degenerate after initially normal development. The HSPs all share the principal clinical feature of progressive lower limb spastic paralysis, and are subdivided into pure and complicated forms, depending on the presence of additional neurological or non-neurological features.1,2
The pure HSPs tend to be associated with neurodegeneration, rather than abnormal development, and histopathological studies in pure HSP show a length-dependent "dying back" of the terminal ends of the corticospinal tract axons, with the longest axons being involved first.1 The SPG4 gene, spastin, is the most important pure HSP gene, being responsible for approximately 40% of definite autosomal dominant pure HSP and a smaller proportion of sporadic cases and cases with uncertain family history.3,4 The 616 amino acid spastin protein is a widely expressed AAA (ATPases associated with diverse cellular
This article has been cited by other articles:
-
Tarrade, A., Fassier, C., Courageot, S., Charvin, D., Vitte, J., Peris, L., Thorel, A., Mouisel, E., Fonknechten, N., Roblot, N., Seilhean, D., Dierich, A., Hauw, J. J., Melki, J.
(2006). A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum Mol Genet
15: 3544-3558
[Abstract] [Full Text] -
Beetz, C., Nygren, A.O.H., Schickel, J., Auer-Grumbach, M., Burk, K., Heide, G., Kassubek, J., Klimpe, S., Klopstock, T., Kreuz, F., Otto, S., Schule, R., Schols, L., Sperfeld, A. -D., Witte, O. W., Deufel, T.
(2006). High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology
67: 1926-1930
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
